A double-blind, placebo and active controlled, single and multiple rising dose, safety, tolerance, and pharmacokinetic study of TR-701 [DA-70218] in normal healthy adults

Trial Profile

A double-blind, placebo and active controlled, single and multiple rising dose, safety, tolerance, and pharmacokinetic study of TR-701 [DA-70218] in normal healthy adults

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Nov 2016

At a glance

  • Drugs Tedizolid (Primary) ; Linezolid
  • Indications Gram-positive infections; Pneumonia; Skin and soft tissue infections
  • Focus Adverse reactions
  • Acronyms SAD/MAD
  • Sponsors Trius Therapeutics
  • Most Recent Events

    • 15 Nov 2016 Results of this and one other phase 1 study assessing ophthalmologic and neurologic clinical examinations published in the American Journal of Therapeutics
    • 17 Jun 2016 Results of a retrospective analysis (n=40) published in the Journal of Antimicrobial Chemotherapy
    • 07 Aug 2013 Results published in Pharmacotherapy.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top